High Tech Pharm Co. Ltd (106190) — Capital Reinvestment Ratio
Latest as of September 2025:
0.08x
High Tech Pharm Co. Ltd (106190) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩6.60 Billion) in capital expenditures (₩516.00 Million). See 106190 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.08x
Capex / Operating Cash Flow
Operating Cash Flow
₩6.60 Billion
KRW
Capital Expenditures
₩516.00 Million
KRW
Data as of
Sep 2025
Most recent filing
High Tech Pharm Co. Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks High Tech Pharm Co. Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for High Tech Pharm Co. Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for High Tech Pharm Co. Ltd from 2014 to 2024. For live market cap and broader valuation context, see High Tech Pharm Co. Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.15x | ₩14.69 Billion | ₩2.13 Billion | ▼ -91.7% |
| 2023 | 1.75x | ₩2.91 Billion | ₩5.09 Billion | ▲ +1310.7% |
| 2021 | 0.12x | ₩6.93 Billion | ₩859.60 Million | ▼ -85.7% |
| 2019 | 0.87x | ₩2.48 Billion | ₩2.16 Billion | ▼ -47.9% |
| 2018 | 1.67x | ₩5.38 Billion | ₩8.96 Billion | ▼ -19.4% |
| 2017 | 2.07x | ₩5.45 Billion | ₩11.27 Billion | ▼ -87.2% |
| 2016 | 16.13x | ₩1.45 Billion | ₩23.35 Billion | ▲ +950.2% |
| 2015 | 1.54x | ₩12.71 Billion | ₩19.52 Billion | ▲ +66.5% |
| 2014 | 0.92x | ₩10.17 Billion | ₩9.38 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow